Mark G. Edwards, Director at ACELRX PHARMACEUTICALS INC (ACRX), bought 25,000 shares at $1.78 ($45K) on 2019-11-12, disclosed to the SEC on 2019-11-12.
Open-market purchase of $44k ACRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| ACRX | BUY | 2018-11-15 | $58K | — | Filing → |
| ACRX | BUY | 2018-08-08 | $15K | — | Filing → |
| ACRX | BUY | 2018-06-05 | $17K | — | Filing → |